News

The new US patent, which has 22 claims, includes assessment of heart rate in zebrafish and use of microplates for high-throughput screening. Patricia McGrath, president and CEO of

This was an exploratory human proof of concept efficacy trial to investigate different dosing regimens and routes of administration for Juvidex (Mannose-6-Phosphate) to assess the feasibility of developing

Financial Results IVAX Diagnostics reported loss for the fourth quarter of 2008 was $465,000, compared with net loss of $1,892,000 for the fourth quarter of 2007. Excluding the

Diagnostic Imaging International (DIIG) and Canadian Teleradiology Services (CTS) have entered into an acquisition agreement whereby DIIG acquired all of the outstanding shares of CTS. In conjunction with

According to Meda, the Edluar contains the well-known substance zolpidem and uses Orexo’s patented sublingual tablet formulation. The collaboration agreement with Orexo entitles it to a milestone payment

This first manufacturing unit is set up, according to the European and the FDA guidelines; it allows the production of clinical batches and will allow for the manufacture

AGI Therapeutics has announced positive results in a Phase II proof of concept study of AGI-004 in the control of chemotherapy-induced diarrhea. The results showed a statistically significant

Mr Lapointe is currently CEO of Sigma-Tau Pharmaceuticals, a company engaged in the development and commercialization of medicines for patients with rare diseases. Sigma-Tau is Dor’s North American

Cook Medical, a provider of medical devices, has reported positive results from an 11-month clinical study on Biodesign, a vaginal erosion repair graft for the treatment of vaginal